by Jake Ciszewski | Jan 15, 2024
Cynthia Qi, Health Economics Outcomes Researcher at Argenx, discusses myasthenia gravis and real-life data. Transcription: Hello, everyone. My name is Cynthia Qi. I am a Health Economics Outcomes Researcher at Argenx. I’ve been working in...
by Jake Ciszewski | Jan 12, 2024
Kimberly Moran, PhD, MBA, Head of US Rare Diseases at UCB, discuses new treatment options for myasthenia gravis, Transcription: One, we don’t make the clinical decisions. That’s what healthcare practitioners do. Most of their job is to really understand...
by Jake Ciszewski | Jan 10, 2024
Robin Kate Kelley, MD, Professor of Clinical Medicine Hematology/IOncology, University of California, San Francisco, describes the need for better treatment plans for patients with biliary tract cancer. Transcription: Interestingly, the perihelia and distal...
by Jake Ciszewski | Jan 7, 2024
Tuan Vu, MD Department of Neurology, University at Tampa Florida, discusses the ADAPT-SC study for the treatment of patients with generalized myasthenia gravis (gMG) Transcription: As this turns out, the efficacy seems almost equal. Then you look at the results,...
by Jake Ciszewski | Jan 6, 2024
Robin Kate Kelley, professor of clinical medicine in the division of hematology/oncology, University of California, San Francisco, dissects biliary tract cancer. Transcription: My name is Katie Kelley, and I’m a GI Medical Oncologist at the University of...
